search

Active clinical trials for "Hypertension, Pulmonary"

Results 931-940 of 944

Evaluation of the Prevalence of Pulmonary Hypertension in Adult Patients With Sickle Cell Disease...

Sickle Cell Disease

Recent data show that pulmonary hypertension (PH), defined by a tricuspid regurgitation jet (TRJ) velocity > or equal at 2.5m/s on Doppler echocardiography, is present in about 30% of adults with sickle cell disease (SCD) and is associated with poor prognosis. However in SCD the occurrence of PH (defined by mean pulmonary arterial pressure (mPAP)> or equal at 25 mmHg) is related to at least 3 mechanisms: PH due to hyperkinetic state with high cardiac output (CO) but normal pulmonary vascular resistance (PVR <160 dynes), or postcapillary PH (pulmonary capillary wedge pressure PCWP >15 mmHg), or precapillary pulmonary arterial hypertension (PAH) defined by mPAP > or equal at 25 mmHg, PCWP< or equal at 15 mmHg and PVR > or equal at 160 dynes.The aim of this study is to evaluate in a French population of adults with sickle cell disease the characteristics, prevalence and prognosis of pulmonary hypertension.

Unknown status7 enrollment criteria

Iodine Subtraction Mapping in the Diagnosis of Chronic Pulmonary Thromboembolic Disease

Chronic Thromboembolic Pulmonary Hypertension

Chronic thromboembolic pulmonary hypertension (CTEPH) is a severe but treatable disease that is commonly underdiagnosed. Computed tomography lung subtraction iodine mapping (CT-LSIM) in addition to standard CT pulmonary angiography (CTPA) may improve the evaluation of suspected chronic pulmonary embolism and improve the diagnostic pick up rate. The investigators aim to recruit 100 patients suspected of having CTEPH and perform CT-LSIM scans in addition to the current gold standard test of nuclear medicine test (lung single photon emission computed tomography (SPECT) imaging) as a pilot study which will contribute to and inform the definitive trial. The diagnostic accuracy of CT-LSIM and lung SPECT will be compared. The primary outcome of the full definitive study is non-inferiority of CT-LSIM versus lung SPECT imaging.

Unknown status6 enrollment criteria

Plethismographic Perfusion Index in Neonates

Patent Ductus ArteriosusPersistent Pulmonary Hypertension of the Newborn

Photoplethismography will be measured and compared in newborns suffering from patent ductus arteriosus and normal controls.

Unknown status2 enrollment criteria

Registry of Sarcoidosis Associated Pulmonary Hypertension (RESAPH)

SarcoidosisPulmonary Hypertension

Registry to follow patients with sarcoidosis associated pulmonary hypertension

Unknown status4 enrollment criteria

Relation Between Mean Pulmonary Artery Pressure and Pulmonary Acceleration Time and Comparison With...

Pulmonary Hypertension

Since the pulmonary artery hypertension is defined based on MPAP and the two previous formulae relating MPAP and PAT were derived in western population, the investigator planned to conduct a prospective study to derive a new formula for measuring MPAP from PAT in Indian population and compare the accuracy of all the three formulae

Unknown status2 enrollment criteria

A New Device for Measuring of Lung Photoplethysmography and Pulmonic Arterial Saturation

Patent Ductus ArteriosusPulmonary Hypertension

To evaluate feasibility of photoplethysmography (PPG) of pulmonary arteries in adults children and neonates and to compare normal controls to premature newborns suffering from patent ductus arteriosus and neonates suffering from pulmonary hypertension.

Unknown status2 enrollment criteria

Lung Perfusion Measured With Dual-Energy CT in Patients With Chronic Thromboembolic Pulmonary Hypertension:...

Multidetector Computed TomographyPulmonary Embolism and Thrombosis1 more

A comparative, observational, cross-sectional and prolective diagnostic test study, including patients that have had a right heart catheterization and were referred for a CT pulmonary angiography as part of their imaging workup protocol for pulmonary hypertension. Dual-energy computed tomography (DECT) pulmonary angiography was performed on each patient to obtain perfusion maps and do a quantitative analysis. Segments with and without perfusion defects according to significant differences in the quantitative values, were defined as compatible or not with chronic thromboembolism. To assess the accuracy of the method and evaluate its performance, these results were compared with the sole results from the right heart catheterization, known to be the gold standard diagnostic tool.

Unknown status2 enrollment criteria

Integrated Computational modelIng of Right Heart Mechanics and Blood Flow Dynamics in Congenital...

Congenital Heart DiseasePulmonary Hypertension

Advances in paediatric cardiology and cardiac surgery have enabled the survival of most patients born with congenital heart disease (CHD) into adulthood. Many CHD patients have undergone palliative or reparative surgery earlier in life. As patients survive into adulthood, they may need intervention or surgery for residual haemodynamic lesions. This is because they are at risk of arrhythmias secondary to structure heart disease and are susceptible to acquired heart disease. In these patients, pre-operative and post-operative evaluation of right ventricular (RV) structure (shape and volume) and function is an essential component of clinical management. Advances have been made in cardiac imaging so that accurate assessment of the right heart chamber in terms of its structure, function and physiology is possible. However, this technology has as yet never been applied in an effort to comprehensively assess RV structure, function and physiology. Cardiac Magnetic Resonance (CMR) will be used in this comprehensive assessment of structure and function. Thus, this research will allow development of a comprehensive integrated biomedical engineering (BME) R&D platform for in-depth study and clinical diagnosis of the RV structure-function relationship and physiology and its association with biomarker, and exercise capacity in CHD.

Unknown status25 enrollment criteria

Taiwan Cohort - Chronic ThromboEmbolic Pulmonary Hypertension Registry

The Geodemographics of CTEPH in Taiwan

The diagnosis of chronic thromboembolic pulmonary hypertension (CTEPH) is difficult for numerous reasons and is related with a poor prognosis. In Taiwan, the incidence of CTEPH and its clinical features are unknown. This study aims at evaluating the prevalence, clinical characteristics, and management of CTEPH in a Taiwanese cohort. Primary objective: - To investigate the geodemographics of CTEPH in Taiwan Secondary objectives: To characterize the demographics and clinical presentation of patients with CTEPH To describe the real-world management and treatment outcome of patients with CTEPH To identify the risk factors of CTEPH To assess the relationship between risk factors/patients' characteristics and clinical outcomes for CTEPH To evaluate the prognosis of CTEPH in Taiwan using survival assessment

Unknown status7 enrollment criteria

CTEPH in Patients With Prior Pulmonary Embolism and Risk Score Validation

Chronic Thromboembolic Pulmonary HypertensionPulmonary Embolism

CTEPH-SOLUTION aims to create a risk score for the early detection of Chronic Thrombo-Embolic Pulmonary Hypertension (CTEPH) among patients with previous pulmonary embolism. The risk score, created on retrospective data, will be validated on newly diagnosed pulmonary embolism patients.

Unknown status3 enrollment criteria
1...939495

Need Help? Contact our team!


We'll reach out to this number within 24 hrs